FRTX — Fresh Tracks Therapeutics Share News
0.000.00%
Last trade - 00:00- $5.59m
- -$5.28m
- $8.01m
Brief: Fresh Tracks Therapeutics Publishes Preclinical Data For FRTX-02
Fresh Tracks Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Fresh Tracks Therapeutics Reports Third Quarter 2022 Financial Results And Provides Corporate Update
Fresh Tracks Therapeutics Inc expected to post a loss of $1.89 a share - Earnings Preview
Fresh Tracks Therapeutics Inc expected to post a loss of $1.89 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Charter Communications, Guild Holdings, Waste Management
Brief: Fresh Tracks Therapeutics Says Board Appointed Deepak Chadha, Co's Chief Research & Development Officer, To Additional Position Of Chief Operating Officer
Fresh Tracks Therapeutics jumps on lead drug study progress
Brief: Fresh Tracks Therapeutics Initiates Multiple Ascending Dose Portion Of Phase 1 Study Of DYRK1A Inhibitor FRTX-02
Brief: Brickell Biotech - Files Prospectus Related To Resale, From Time To Time, Of Up To 1.8 Million Shares Of Common Stock, By Lincoln Park Capital Fund, LLC
Brief: Brickell Biotech - On Aug 30, Audit Committee Said Interim Financial Statements In Co’s Report For Quarter Ended June 30, 2022 Should No Longer Be Relied Upon
Brief: Brickell Biotech Inc - On August 19, 2022, Received A Notice From Listing Qualifications Department Of The Nasdaq Stock Market
Brickell Biotech Inc reports results for the quarter ended in June - Earnings Summary
Brief: Brickell Biotech Reports Q2 2022 Results
Brickell Biotech Inc expected to post a loss of $1.44 a share - Earnings Preview
Brief: Brickell Biotech- Board Of Co Adopted Amended And Restated Bylaws To Decrease The Minimum Number Of Directors From Five Members To Four Members
Brief: Brickell Biotech Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Brickell Biotech Announces 1-For-45 Reverse Stock Split
Brief: Brickell Biotech Inc Entered Into A Subscription And Investment Representation Agreement